CAF Specific Expression of Podoplanin May Be Dispensable for the Malignancy of Malignant Melanoma
Molecular Carcinogenesis · 2025-02 · 64 (2) · 215-220
DOI: 10.1002/mc.23841 ↗At a glance
Journal article in Molecular Carcinogenesis, published online on 2024-11-08. Written by Saskia Tauch and 7 co-authors. Institution: Division Signal Transduction and Growth Control, German Cancer Research Center (DKFZ-ZMBH Alliance), Heidelberg, Germany. Major MEDLINE topics: Membrane Glycoproteins, Melanoma, Cancer-Associated Fibroblasts, Skin Neoplasms. Cited 3 times so far (Crossref); 16 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Within the tumor microenvironment (TME), cancer‐associated fibroblasts (CAFs) were shown to be an active and pivotal cell population, supporting many protumorigenic mechanisms. Podoplanin (PDPN)‐positive CAFs are of special interest since their abundance correlated with a worse prognosis for patients of different cancer entities, including malignant melanoma. In this study, we applied a loss‐of‐function approach in an in vivo mouse melanoma model to evaluate the contribution of CAF‐specific PDPN expression to melanoma formation and progression. Surprisingly, despite its prominent expression in CAFs deletion of PDPN in this cell type did neither affect the onset, nor growth of MM tumors. These data imply that PDPN expression in CAFs represents a biomarker for poor prognosis but does not serve as a useful target for stroma‐directed therapy of malignant melanoma.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division Signal Transduction and Growth Control, German Cancer Research Center (DKFZ-ZMBH Alliance), Heidelberg, Germany.
- Division of Vascular Oncology and Metastasis, German Cancer Research Center (DKFZ-ZMBH Alliance), Heidelberg, Germany.
- European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
- DKFZ-Hector Cancer Institute, University Medical Centre Mannheim, Mannheim, Germany.
ORCID profiles: Peter Angel
Cite
APA
Tauch, S., Kast, B., Lohr, S., Kemm, L., Sator-Schmitt, M., Gengenbacher, N., Augustin, H. G., & Angel, P. (2025). CAF Specific Expression of Podoplanin May Be Dispensable for the Malignancy of Malignant Melanoma. Molecular Carcinogenesis, 64(2), 215-220. https://doi.org/10.1002/mc.23841
Vancouver
Tauch S, Kast B, Lohr S, Kemm L, Sator-Schmitt M, Gengenbacher N, et al. CAF Specific Expression of Podoplanin May Be Dispensable for the Malignancy of Malignant Melanoma. Molecular Carcinogenesis. 2025;64(2):215-220. doi:10.1002/mc.23841
BibTeX
@article{Tauch2025,
author = {Tauch, Saskia and Kast, Bettina and Lohr, Sabrina and Kemm, Lowis and Sator-Schmitt, Melanie and Gengenbacher, Nicolas and Augustin, Hellmut G and Angel, Peter},
title = {CAF Specific Expression of Podoplanin May Be Dispensable for the Malignancy of Malignant Melanoma},
journal = {Molecular Carcinogenesis},
year = {2025},
volume = {64},
number = {2},
pages = {215--220},
doi = {10.1002/mc.23841}
}
EUVIMED